Active	Status	Sponsor type	Region	Phase	Filter
10 Active 0 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Talaty, Pooja
NCT06062875: Effects of TNF Blockade on Human BPH/LUTS	Recruiting	2	70	US	Adalimumab, Placebo will be administered subcutaneously every 2 weeks, for a total of 6 injections.	NorthShore University HealthSystem, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Benign Prostatic Hyperplasia (BPH)	04/28	06/28
PRESERVE, NCT04972097: Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue	Active, not recruiting	N/A	121	US	Irreversible Electroporation, The NanoKnife System	Angiodynamics, Inc.	Prostate Cancer	07/24	07/24
GenBx, NCT05295407: Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy	Recruiting	N/A	1000	US	Genetic Assessment	NorthShore University HealthSystem, Northwestern University, Johns Hopkins University, GoPath Diagnostics	Prostate Cancer	12/24	12/25
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift	Recruiting	N/A	206	Europe, US	iTind, UroLift	Olympus Corporation of the Americas	Benign Prostatic Hyperplasia (BPH)	12/25	12/30
WATER IV PCa, NCT06651632: WATER IV Prostate Cancer	Recruiting	N/A	280	Europe, Canada, US, RoW	Aquablation Therapy, Radical Prostatectomy	PROCEPT BioRobotics	Localized Prostate Cancer	07/27	01/37
NCT06054867: PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System	Active, not recruiting	N/A	22	US	Robotic Waterjet Treatment, Aquablation therapy	PROCEPT BioRobotics	Localized Prostate Cancer	04/25	04/25
NCT06051942: PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs	Recruiting	N/A	125	US, RoW	Robotic Waterjet Treatment, Aquablation therapy	PROCEPT BioRobotics	Benign Prostatic Hyperplasia, Localized Prostate Cancer	08/25	05/26
NCT05898932: Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes	Recruiting	N/A	300	US	Medical Management, Surgical Management	Northwestern University, NorthShore University HealthSystem, University of Chicago	Benign Prostatic Hyperplasia	08/26	08/26
NCT05608694: MRI Screening in Men at High Risk of Developing Prostate Cancer	Recruiting	N/A	250	US	Prostate MRI	University of Chicago	Prostate Cancer Screening	03/37	03/39
Prabhu, Rahul
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift	Recruiting	N/A	206	Europe, US	iTind, UroLift	Olympus Corporation of the Americas	Benign Prostatic Hyperplasia (BPH)	12/25	12/30